HCA Healthcare, Inc. $HCA Shares Sold by Voya Investment Management LLC

Voya Investment Management LLC lowered its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 9.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 69,169 shares of the company’s stock after selling 7,116 shares during the period. Voya Investment Management LLC’s holdings in HCA Healthcare were worth $29,480,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Riversedge Advisors LLC acquired a new position in shares of HCA Healthcare in the third quarter worth $292,000. Wedmont Private Capital increased its position in HCA Healthcare by 2.4% during the 3rd quarter. Wedmont Private Capital now owns 3,560 shares of the company’s stock worth $1,558,000 after purchasing an additional 84 shares in the last quarter. Orser Capital Management LLC acquired a new stake in shares of HCA Healthcare during the 3rd quarter worth about $831,000. Norway Savings Bank raised its position in shares of HCA Healthcare by 9.6% in the third quarter. Norway Savings Bank now owns 4,255 shares of the company’s stock valued at $1,813,000 after buying an additional 374 shares during the last quarter. Finally, Canandaigua National Bank & Trust Co. boosted its position in HCA Healthcare by 2.3% during the third quarter. Canandaigua National Bank & Trust Co. now owns 4,458 shares of the company’s stock worth $1,900,000 after acquiring an additional 102 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares in the company, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on HCA. Raymond James Financial set a $525.00 price target on HCA Healthcare in a research note on Monday, October 27th. Royal Bank Of Canada raised their price target on HCA Healthcare from $482.00 to $525.00 and gave the stock an “outperform” rating in a research note on Friday. Jefferies Financial Group increased their price objective on shares of HCA Healthcare from $485.00 to $525.00 and gave the stock a “buy” rating in a report on Tuesday, October 28th. KeyCorp upped their price target on shares of HCA Healthcare from $465.00 to $475.00 and gave the stock an “overweight” rating in a research report on Monday, October 27th. Finally, Mizuho boosted their price objective on shares of HCA Healthcare from $505.00 to $520.00 and gave the company an “outperform” rating in a research note on Thursday. Fourteen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $479.00.

HCA Healthcare Stock Up 1.3%

HCA opened at $472.69 on Friday. The company has a market cap of $107.87 billion, a P/E ratio of 18.27, a P/E/G ratio of 1.40 and a beta of 1.36. The company has a 50 day moving average of $470.12 and a two-hundred day moving average of $417.03. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $520.00.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The firm’s revenue was up 9.6% on a year-over-year basis. During the same period in the prior year, the company earned $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be given a $0.72 dividend. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is 11.13%.

HCA Healthcare Company Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.